BRIEF published on 05/08/2026 at 22:35, 5 months 21 days ago Integrated BioPharma annonce une baisse de son chiffre d'affaires trimestriel Résultats Financiers Perte Nette Baisse Des Revenus Perte D'exploitation Fabrication Sous Contrat
BRIEF published on 05/08/2026 at 22:35, 5 months 21 days ago Integrated BioPharma Reports Decrease in Quarterly Revenue Financial Results Revenue Decline Net Loss Operating Loss Contract Manufacturing
PRESS RELEASE published on 05/08/2026 at 22:30, 5 months 21 days ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026 Integrated BioPharma, Inc. reports $10.1M revenue for Q1 2026, a 27.3% decrease from Q1 2025. Operating loss of $1.1M in Q1 2026. Financial summary provided Financial Results Revenue Quarterly Report Operating Loss Integrated BioPharma
BRIEF published on 02/11/2026 at 22:35, 8 months 18 days ago Integrated BioPharma annonce ses résultats financiers du quatrième trimestre 2025 Résultats Financiers Perte Nette Baisse Des Revenus Perte D'exploitation Dépendance Du Client
BRIEF published on 02/11/2026 at 22:35, 8 months 18 days ago Integrated BioPharma Announces Q4 2025 Financial Results Financial Results Revenue Decline Net Loss Operating Loss Customer Dependency
PRESS RELEASE published on 02/11/2026 at 22:30, 8 months 18 days ago Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 Integrated BioPharma, Inc. reports financial results for Q4 2025, showing a $1.3M decrease in revenue and operating loss compared to Q4 2024. Key financial details provided Financial Results Revenue Decrease Operating Loss Integrated BioPharma Quarterly Performance
BRIEF published on 11/10/2025 at 21:55, 11 months 19 days ago Integrated BioPharma publie ses résultats financiers pour le troisième trimestre 2025 Résultats Financiers Baisse Des Revenus Résultat D'exploitation Revenu Net Fabrication Sous Contrat
BRIEF published on 11/10/2025 at 21:55, 11 months 19 days ago Integrated BioPharma Reports Financial Results for Q3 2025 Financial Results Net Income Revenue Decline Operating Income Contract Manufacturing
PRESS RELEASE published on 11/10/2025 at 21:50, 11 months 19 days ago Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 Integrated BioPharma, Inc. reports financial results for the quarter ended September 30, 2025, with $12.7 million revenue and insights on operating income and net income Financial Results Revenue Net Income Operating Income Integrated BioPharma
BRIEF published on 09/23/2025 at 21:45, 1 year 1 month ago Integrated BioPharma Reports Fiscal Year 2025 Results Financial Results Revenue Growth Net Income Operating Income Contract Manufacturing
Published on 10/30/2026 at 12:20, 2 hours 5 minutes ago Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)
Published on 10/30/2026 at 12:00, 2 hours 25 minutes ago Aztec Minerals Strengthens Technical Management Team
Published on 10/29/2026 at 22:01, 16 hours 24 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/29/2026 at 21:30, 16 hours 55 minutes ago Shelfie Announces Amendments to Previously Announced Acquisition of Aspect
Published on 10/30/2026 at 13:50, 35 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/30/2026 at 13:48, 36 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 10/30/2026 at 12:00, 2 hours 25 minutes ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 10/30/2026 at 12:00, 2 hours 25 minutes ago Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:00, 6 hours 25 minutes ago Neoen secures AUD 1.8 billion in debt financing to support renewable energy portfolio in Australia
